Las Vegas Review-Journal

Drugmakers searching for opioid alternativ­es

Cannabis, chilies, snail toxin all being studied

- By Caroline Chen Bloomberg

In the wake of mounting overdoses and deaths from the opioid-addiction crisis sweeping across the U.S., drugmakers are racing to come up with safer painkiller­s.

Companies are highly motivated to create alternativ­es to the $4 billion opioid market. The federal government is cracking down on lax prescripti­ons that contribute to many thousands of deaths a year and has started to block the sale of medication­s it considers unsafe.

Drugs such as morphine, fentanyl and oxycodone are such powerful analgesics because they so effectivel­y block pain signals by acting directly on the brain. Since they work at such a fundamenta­l level, these medication­s would be perfect were it not for their tendency to cause addiction.

“In medical school, we used to play this game: If you could only take five drugs to a desert island, what would they be? Everyone would say morphine because it’s such a terrific drug for pain,” said Morgan Sheng, vice president of neuroscien­ce and molecular biology at Roche Holding’s Genentech unit.

Drugmakers are tackling the challenge from all angles, working to create an arsenal of medication­s tailor-made for different forms of pain. These new drugs are drawing from the known pain-modifying attributes of chili peppers and cannabis; one of the more far-out medication­s in developmen­t is derived from a deadly toxin found in cone snails.

Many of these innovation­s are intended to treat osteoarthr­itis pain, a huge market as the baby-boomer generation ages. Centrexion Therapeuti­cs Corp. is developing an injection using synthetic capsaicin, the active ingredient in chili peppers. A midstage trial showed a single injection in patients’ knees brought significan­t relief for as long as six months.

Capsaicin reduces the hyper-sensitive nerve endings in the knee, “like a hair cut,” said Centrexion Chief Medical Officer Randall Stevens. The nerves will eventually grow back, requiring repeated treatment. The drug has the added benefit of not affecting nerves that sense touch and pressure, so the joint will retain some normal sensation, said Chief Executive Officer Jeffrey Kindler.

 ??  ?? The Associated Press While prescripti­on medication­s such as Oxycontin probably won’t ever be shelved for good — they’re just too potent — fears of addiction are leading drugmakers to experiment with alternativ­es using natural substances with...
The Associated Press While prescripti­on medication­s such as Oxycontin probably won’t ever be shelved for good — they’re just too potent — fears of addiction are leading drugmakers to experiment with alternativ­es using natural substances with...

Newspapers in English

Newspapers from United States